Vimarsana
Biggest News Aggregation in the World

Page 10 - Veronica Eames News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Veronica Eames. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Veronica Eames Today - Breaking & Trending Today

9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference - Vimarsana News

9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference

09.03.2022 - RALEIGH, NC / ACCESSWIRE / March 9, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today that John Temperato, President & Chief ...

9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder - Vimarsana News

9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder

RALEIGH, NC / ACCESSWIRE / March 2, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced

9 Meters Biopharma : Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease - Form 8-K - Vimarsana News

9 Meters Biopharma : Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease - Form 8-K

9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease RALEIGH, NC... | February 28, 2022

9 Meters Biopharma Announces Publication of Data on Larazotide for the Treatment of Multisystem Inflammatory Syndrome in Children (MIS-C) - Vimarsana News

9 Meters Biopharma Announces Publication of Data on Larazotide for the Treatment of Multisystem Inflammatory Syndrome in Children (MIS-C)

RALEIGH, NC / ACCESSWIRE / February 25, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced

9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer - Vimarsana News

9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer

9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace